Premium Reports
Radiation Therapy 2017

Radiation Therapy 2017
Technology Outpacing Interoperability

Authored by: | Read Time: 3 minutes

Since KLAS last reported on radiation therapy in 2014, the overall high-performing market has seen some significant changes—adoption of Elekta’s go-forward platform (the Versa HD) has increased, and Varian customers have seen positive shifts in support and relationships. This report seeks to help provider organizations better understand radiation therapy vendor performance in the areas of functionality, support, and integration and will also examine the widening gap between the highest and lowest performers in the treatment planning market.

Key Topics

  1. Versa HD Making Elekta More Competitive
  2. Varian Improving Customer Relationships; Accuray Spread Too Thin
  3. Accuray Equipment on an Island Due to Proprietary Treatment Planning Software
  4. Treatment Planning Systems: Varian Customers Committed for the Long Haul; Philips’ Development Too Little, Too Late for Some

 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2019 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.